New drug tested for Tough-to-Treat blood cancer
Disease control
Not yet recruiting
This early-stage study is testing a new drug called MS-553 in adults with chronic lymphocytic leukemia or small lymphocytic lymphoma that has returned or stopped responding to previous treatments. The main goal is to check the drug's safety and side effects in about 12 patients. …
Phase: PHASE1, PHASE2 • Sponsor: MingSight Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC